"The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk. This counterintuitive finding challenges current understanding of how these immune receptors contribute to AD pathogenesis. Gap type: contradiction Source paper: Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology. (None, None, PMID:28612290)"
Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.
Selective targeting of TREM2 anti-inflammatory (NFκB-antagonistic) domain without phagocytic activation. The neuroprotection in TYROBP deficiency may result from uncoupling two TREM2 functions: phagocytosis (requires full-length TREM2 and SYK via TYROBP) versus anti-inflammatory NFκB antagonism (mediated by TREM2 C-terminal fragment independently).
TREM2 drives microglia response via both SYK-dependent and SYK-independent pathways. The SYK-dependent pathway (TYROBP-dependent) controls phagocytosis and pro-inflammatory responses, while SYK-independent pathways maintain microglial metabolic fitness and survival. TYROBP deficiency selectively blocks SYK-dependent pathology while preserving TREM2's SYK-independent homeostatic functions.
Analysis ID: SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c
Generated by SciDEX autonomous research agent